» Articles » PMID: 38008882

ARAP1 Negatively Regulates Stress Fibers Formation and Metastasis in Lung Adenocarcinoma Via Controlling Rho Signaling

Overview
Journal Discov Oncol
Publisher Springer
Specialty Oncology
Date 2023 Nov 26
PMID 38008882
Authors
Affiliations
Soon will be listed here.
Abstract

Small GTPases regulate multiple important cellular behaviors and their activities are strictly controlled by a mass of regulators. The dysfunction or abnormal expression of small GTPases or their regulators was frequently observed in various cancers. Here, we analyzed the expression and prognostic correlation of several GTPases and related regulators based on the TCGA database and found that Ankyrin Repeat and PH Domain 1 (ARAP1), a GTPase activating protein (GAP), is reduced in lung adenocarcinoma tissues compared to normal tissues and displays a positive correlation with overall survival (OS) and progression-free survival (PFS) of patients with lung adenocarcinoma. qPCR and western blot verified that ARAP1 is frequently downregulated in lung adenocarcinoma tumor tissues and cancer cells, and its downregulation might be mediated by epigenetic modification. Moreover, metastatic assays showed that overexpression of ARAP1 significantly inhibits metastasis of lung adenocarcinoma in vitro and in vivo. We further demonstrated that Rho signaling inhibition, mediated by RhoGAP activity of ARAP1, majorly contributes to suppressing migration and invasion of lung adenocarcinoma cancer cells via inhibiting stress fibers formation. In summary, this study indicates that ARAP1 may serve as a potential prognostic predictor and a metastatic suppressor in lung adenocarcinoma via its RhoGAP activity.

Citing Articles

Adaptation responses to salt stress in the gut of .

Lee H, Yeo H, Park J, Kang K, Yi S, Kim K Anim Cells Syst (Seoul). 2025; 29(1):84-99.

PMID: 39839657 PMC: 11749108. DOI: 10.1080/19768354.2025.2451413.


Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder.

Khan H, Harripaul R, Mikhailov A, Herzi S, Bowers S, Ayub M Sci Rep. 2024; 14(1):9230.

PMID: 38649688 PMC: 11035605. DOI: 10.1038/s41598-024-57942-x.

References
1.
Nadaraja S, Schledermann D, Herrstedt J, Ostrup O, Ditzel H . ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy. Acta Oncol. 2019; 59(1):40-47. DOI: 10.1080/0284186X.2019.1657941. View

2.
Dawson M, Kouzarides T . Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150(1):12-27. DOI: 10.1016/j.cell.2012.06.013. View

3.
Vigil D, Cherfils J, Rossman K, Der C . Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nat Rev Cancer. 2010; 10(12):842-57. PMC: 3124093. DOI: 10.1038/nrc2960. View

4.
Li J, Zhang J, Hou W, Yang X, Liu X, Zhang Y . Metabolic control of histone acetylation for precise and timely regulation of minor ZGA in early mammalian embryos. Cell Discov. 2022; 8(1):96. PMC: 9515074. DOI: 10.1038/s41421-022-00440-z. View

5.
Biswas S, Rao C . Epigenetics in cancer: Fundamentals and Beyond. Pharmacol Ther. 2017; 173:118-134. DOI: 10.1016/j.pharmthera.2017.02.011. View